December 30, 2008
Transparency
information
Download PDF
December 22, 2008
Galapagos
and GlaxoSmithKline expand osteoarthritis alliance
Download PDF
December 18, 2008
Galapagos
extends drug discovery collaboration with Amgen into 2010
Download PDF
December 9, 2008
Galapagos
and Dart Neuroscience LLC sign drug discovery and compound management
agreements
Download PDF
November 26, 2008
MorphoSys
and Galapagos enter alliance to co-develop novel therapeutic antibodies
in bone & joint disease
View
webcast presentation
Download PDF
November 18, 2008
Galapagos
and Merck Serono enter new collaboration agreements
Download PDF
November 14, 2008
Galapagos
business update
Download PDF
November 5 , 2008
Galapagos
sells San Diego chemistry facility to ChemVentures
Download PDF
October 29, 2008
Galapagos
and CHDI enter new collaboration agreements
Download PDF
October 27 , 2008
Nanocort®
demonstrates safety and good response in Phase I/II trial
Download PDF
September 30 , 2008
Delta
Lloyd acquires 5.4% of Galapagos
Download PDF
September 15 , 2008
Transparency
information: Galapagos NV
Download PDF
August 26, 2008
Galapagos
acquires structure-based drug discovery from Sareum
Download PDF
August 12, 2008
UCB
transfers UK-based medicinal chemistry program to BioFocus DPI
Download PDF
August 8, 2008
Strong
revenue growth and sharp improvement of net result for Galapagos
in 1H 2008
Download PDF
July 23, 2008
Galapagos
transfers predictive drug discovery databases to EMBL’s
European Bioinformatics Institute
Download PDF
July 22, 2008
NIH
extends agreement with Galapagos
Download PDF
July 18, 2008
Galapagos
announces first milestone in osteoporosis collaboration with Lilly
Download PDF
July 17, 2008
Boehringer
Ingelheim licenses drug targets from autoimmune collaboration
with Galapagos
Download PDF
July 2, 2008
Galapagos
creates new warrant plans
Download PDF
June 30, 2008
Galapagos
signs new compound management agreement
Download PDF
June 16, 2008
Galapagos
announces milestone payment of €0.8 million in osteoarthritis
alliance with GlaxoSmithKline
Download PDF
June 3, 2008
William
Garth Rapeport joins Galapagos’ Board of Directors
Download PDF
May 19, 2008
Galapagos
signs research agreement with UCL
Download
PDF
May 16, 2008
Galapagos
business update
Download
PDF
May 6, 2008
Galapagos
and Allergan enter drug discovery collaboration
Download
PDF
April 16 , 2008
Galapagos
licenses clinical rheumatoid arthritis program
Download
PDF
April 14 , 2008
Galapagos
appoints Piet Wigerinck as Senior VP Development
Download
PDF
April 10 , 2008
Bausch
& Lomb and Galapagos sign agreement to collaborate on ophthalmic
disease research
Download
PDF
March 14, 2008
Galapagos
ADR listing operational; CEO presents at Cowen Health Care Conference
in the U.S
Download
PDF
March 7, 2008
Galapagos
announces 2007 full year results
Download
PDF
March 6 , 2008
Galapagos
announces level 1 ADR listing and cancels AIM listing
Download
PDF
February 28, 2008
Galapagos
announces pre-clinical candidates and clinical plans in rheumatoid
arthritis and bone metastasis
Download
PDF
February 27, 2008
Galapagos
trading update
Download
PDF
January 25, 2008
Galapagos
achieves €3.4 million milestone payment from Janssen Pharmaceutica
NV
Download
PDF
January 21, 2008
Galapagos
announces R&D update on 28 February 2008
Download
PDF
January 16, 2008
Galapagos
awarded €4.4 M grant for rheumatoid arthritis drug development
Download
PDF
January 14, 2008
Galapagos
extends drug discovery collaboration with Lilly in nuclear hormone
receptor research
Download
PDF
January 3, 2008
Galapagos
enters into oncology target discovery collaboration with Janssen
Pharmaceutica
Download
PDF
